PET-lipid A (Cascadian Therapeutics)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePET-lipid A (Cascadian Therapeutics)
Drug Alias NamePET-lipid A (Oncothyreon)synthetic Lipid-A analogs (Oncothyreon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 4 agonists
TargetsToll like receptor 4
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCascadian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCascadian Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A